Specialities Pharmaceuticals
This unit has a wide and diverse client base and covers both Private and Institutional sectors. Private sector deals with private pharmacies and private hospitals whereas; Institutional sector deals with Ministries, Charitable Societies, and Government subsidiaries etc.
Commenced operations since 1960, and continuously offering top quality pharmaceutical brands that are approved by FDA and/or EMA.
Addressing the growing requirements of patients, physicians, health care payers with emphasis on specialty-focused innovative medicines that provide significant clinical benefit and value, primarily in the therapeutic areas of:
- Osteoporosis
- Osteoarthritis
- Parkinson’s disease
- Pain-Management
- Psychotic conditions
- Depressive and general anxiety disorders
- Deficit Hyperactivity Disorder
- Peyronie’s disease
- Zyprexa®
- Strattera®
- Cymbalta®
- Forteo®
- Tramal®
- Zaldiar®
- Versatis®
- Apo Go®
- Xiaflex®
- Synvisc one ®
